The molecular origin of FH-I was elucidated by Lifton et al in 1992 who identified a chimeric CYP11B1/CYP11B2 hybrid gene in patients with FH-I [94]. Here, CYP11B2 is linked to glucocorticoid-remediable aldosteronism.